Comparative efficacy and safety of 3-day azithromycin and 10-day penicillin V treatment of group A beta-hemolytic streptococcal pharyngitis in children

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 4, 1996, Pages 1005-1008

  Pacifico, Lucia ^a   Scopetti, Franca ^b   Ranucci, Alessandro ^a   Pataracchia, Marco ^b   Savignoni, Ferdinando ^a   Chiesa, Claudio ^a,c  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b National Health Institute   (Italy)

^c CNR   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; PENICILLIN V;

ANTIBACTERIAL ACTIVITY; CHILD; DIARRHEA; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NOTE; ORAL DRUG ADMINISTRATION; PHARYNGITIS; PRIORITY JOURNAL; STREPTOCOCCUS GROUP A; VOMITING;

EID: 0029915805     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.4.1005     Document Type: Note

References (21)

1. Aujard, Y., I. Boucot, N. Brahimi, D. Chiche, and E. Bingen. 1995 Comparative efficacy and safety of four-day cefuroxime axetil and ten-day penicillin treatment of group A beta-hemolytic streptococcal pharyngitis in children. Pediatr. Infect. Dis. J. 14:295-300.
2. Bernstein, S. H., H. A. Feldman, O. F. Harper, Jr., W. H. Klingensmith, and J. A. Cantor. 1954. Observations in air force recruits of streptococcal diseases and their control with orally administered penicillin. J. Lab. Clin. Med. 44:1-13.
3. Borzani, M., F. Varotto, L. Garlaschi, F. Conio, M. Dell'Olio, and P. Careddu. 1989. Clinical and microbiological evaluation of miocamycin activity against group A streptococci in pediatric patients: three years' incidence of erythromycin-resistant group A streptococci. J. Chemother. 1:35-38.
4. Brook, I. 1984. The role of β-lactamase-producing bacteria in the persistence of streptococcal tonsillar infection. Rev. Infect. Dis. 6:601-607.
5. Chiesa, C., L. Pacifico, F. Nanni, and G. Ravagnan. 1992. Evaluation of culture techniques for GABHS. Am. J. Clin. Pathol. 97:157-158.
6. Dajani, A. S., A. L. Bisno, K. J, Chung, D. T. Durack, M. A, Gerber, E. L. Kaplan, et al. 1988. Prevention of rheumatic fever: a statement for health professionals by the Committee on Rheumatic Fever. Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young, the American Heart Association. Circulation 78:1082-1086.
7. Foulds, G., R. M. Shepard, and R. B. Johnson. 1990. The pharmacokinetics of azithromycin in human serum and tissues. J Antimicrob. Chemother. 25(Suppl. A):73-82.
8. Gerber, M. A., M. F. Randolph, J. Chanatry, L. L. Wright, K. De Meo, and E. L. Kaplan. 1987. Five vs ten days of penicillin V therapy for streptococcal pharyngitis Am. J. Dis Child, 141:224-227.
9. Hamill, G. 1993. Multicenter evaluation of azithromycin and penicillin V in the treatment of acute streptococcal pharyngitis and tonsillitis in children. J. Antimicrob. Chemother. 31(Suppl. E):89-94.
10. Holm, S. E. 1994. Reasons fur failures in penicillin treatment of streptococcal tonsillitis and possible alternatives. Pediatr Infect. Dis. J. 13(Suppl 1):66-69.
11. Kim, K. S., and E. L. Kaplan. 1985. Association of penicillin tolerance with failure to eradicate group A streptococci from patients with pharyngitis. J. Pediatr. 107:681-684.
12. Markowitz, M., M. A. Gerber, and E. L. Kaplan. 1993. Treatment of streptococcal pharyngotonsillitis. reports of penicillin's demise are premature. J. Pediatr. 123:679-685.
13. Moody, M. D., J. Padula, D. Lizana, and C. T. Hall. 1965. Epidemiologic characterization of group A streptococci by T-agglutination and M-precipitalion tests in the public health laboratory. Health Lab. Sci. 2:149-162.
14. Nahata, M. C. 1995. Pharmacokinetics of azithromycin in pediatric patients: comparison with other agents used for treating otitis media and itreptococcal pharyngitis. Pediatr. Infect. Dis. J. 14(Suppl ):39-44.
15. National Committee for Clinical Laboratory Standards. 1993. Approved standard M2-A5. Performance standards for antimicrobial disk susceptibility tests National Committee for Clinical Laboratory Standards, Villanova, Pa.
16. Pacifico, L., G. Mancuso, E. Properzi, G. Ravagnan, A. M. Pasquino, and C. Chiesa. 1995. Comparison of nephelometric and hemolytic techniques for determination of antistreptolysin O antibodies. Am. J. Clin. Pathol. 103:396-399.
17. Pichichero, M. E. 1993. Cephalosporins are superior to penicillin for treatment of streptococcal tonsillopharyngitis: is the difference worth it? Pediatr. Infect. Dis. J 12:268-274.
18. Schwartz, R. H., R. L. Wientzen, Jr., F. Pedreira, E. J. Feroli, G. W. Mella, and V. L. Guandolo. 1981. Penicillin V for group A streptococcal pharyngitis a randomized trial of seven vs ten days' therapy. JAMA 246:1790-1795.
19. Still, J. G. 1993. Azithromycin suspension vs penicillin V suspension in treatment of children with streptococcal pharyngitis. Clin. Pharmacol. Ther. 53:195. (Abstract PII-101)
20. Still, J. G. 1994. Treatment of streptococcal pharyngitis in children with five days of azithromycin suspension, abstr. M67, p. 246. In Abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
21. Still, J. G. 1995. Management of pediatric patients with group A beta-hemolytic streptococcus pharyngitis: treatment options. Pediatr. Infect. Dis J. 14(Suppl.):57-61.